SCTX (Scribe Therapeutics) Total Liabilities: $223.95 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SCTX Scribe Therapeutics Inc SCTX
8 GF Score
Price $22.00
View Full Analysis

What is Scribe Therapeutics Total Liabilities?

Scribe Therapeutics SCTX -13.40% 8 Total Liabilities is $223.95 Mil as of Mar. 2026. GuruFocus rates SCTX with a GF Score™ of 8/100.

Scribe Therapeutics's Total Liabilities for the quarter that ended in Mar. 2026 was $223.95 Mil.

Scribe Therapeutics's quarterly Total Liabilities increased from Mar. 2025 ($0.00 Mil) to Dec. 2025 ($221.64 Mil) and increased from Dec. 2025 ($221.64 Mil) to Mar. 2026 ($223.95 Mil).

Scribe Therapeutics's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2024 ($253.83 Mil) but then declined from Dec. 2024 ($253.83 Mil) to Dec. 2025 ($221.64 Mil).

Scribe Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Scribe Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scribe Therapeutics Total Liabilities Chart

Scribe Therapeutics Annual Data
Trend Dec24 Dec25
Total Liabilities
253.83 221.64

Scribe Therapeutics Quarterly Data
Dec24 Mar25 Dec25 Mar26
Total Liabilities 253.83 0.00 221.64 223.95
SCTX
8GF Score
Scribe Therapeutics Inc SCTX
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scribe Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Scribe Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=69.057+(4.804+127.841
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+19.936+0+0)
=221.64

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=78.219--143.419
=221.64

Scribe Therapeutics's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=79.72+(4.459+128.069
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+11.698+0+0)
=223.95

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=65.208--158.738
=223.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $223.95 Mil mean?
Scribe Therapeutics (SCTX) has a Total Liabilities of $223.95 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Scribe Therapeutics and its competitors.
Is Scribe Therapeutics' Total Liabilities too high?
Scribe Therapeutics' current Total Liabilities is $223.95 Mil. Overall, Scribe Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Scribe Therapeutics' Total Liabilities compare to ?
Scribe Therapeutics' Total Liabilities of $223.95 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Scribe Therapeutics and its competitors. Scribe Therapeutics's current Total Liabilities is $223.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scribe Therapeutics stock overvalued right now?
Scribe Therapeutics (SCTX) has a current Total Liabilities of $223.95 Mil. The current Total Liabilities is $223.95 Mil. Scribe Therapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Scribe Therapeutics (SCTX), the current Total Liabilities is $223.95 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scribe Therapeutics Business Description

Comparable Companies
Address 1150 Marina Village Parkway, Alameda, CA, USA, 94501
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
8GF Score

Get the complete analysis for SCTX

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.00
Price